Zimmer Biomet (ZBH) reported $1.94 billion in revenue for the quarter ended December 2023, representing a year-over-year increase of 6.3%. EPS of $2.20 for the same period compares to $1.88 a year ago.The reported revenue represents a surprise of +0.57% over the Zacks Consensus Estimate of $1.93 billion. With the consensus EPS estimate being $2.15, the EPS surprise was +2.33%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stre ...

Zimmer Biomet (ZBH) came out with quarterly earnings of $2.20 per share, beating the Zacks Consensus Estimate of $2.15 per share. This compares to earnings of $1.88 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 2.33%. A quarter ago, it was expected that this orthopedic device maker would post earnings of $1.59 per share when it actually produced earnings of $1.65, delivering a surprise of 3.77%.Over the last four quarters, t ...

Mohammed Haneefa Nizamudeen Zimmer Biomet's (NYSE:ZBH) stock has been under pressure over the past few years, which appears to be at least in part due to concerns over the impact of GLP-1 agonists. This fear appears to be misplaced though, as it will likely be decades before any negative impact will be felt. In addition, GLP-1 agonists should provide a near-term tailwind by making more patients eligible for surgery. Joint replacement procedures have been increasing 5% annually, and even if the worst-case sc ...

Zimmer Biomet Holdings, Inc. (ZBH) is scheduled to report fourth-quarter and full-year 2023 results on Feb 8, before market open.In the last reported quarter, the company’s earnings of $1.65 exceeded the Zacks Consensus Estimate by 3.8%. Over the trailing four quarters, its earnings outperformed the consensus estimate on three occasions and matched the same once, the average beat being 5.09%.Let’s take a look at how things have shaped up prior to this announcement.Factors at PlayLike its industry competitor ...

Peter Dazeley/The Image Bank via Getty Images Zimmer Biomet (NYSE:ZBH) used to operate under a turnaround business, aiming to close the gap with its major competitor, Stryker (SYK). They spun off their spine and dental divisions and refocused on high-growth areas in knees, hips, extremities, and trauma markets. Zimmer appointed their new CEO, Ivan Tornos, in April 2023, and the management team is currently emphasizing growth acceleration. I am initiating coverage with a 'Buy' rating and a fair value of $140 ...

WARSAW, Ind., Jan. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Louis A. Shapiro, formerly the President and Chief Executive Officer of the Hospital for Special Surgery (HSS), has been appointed to the Board, effective immediately. HSS has been recognized as a leading academic medical center focused on musculoskeletal health – it was ranked #1 in U.S. orthopedics hospitals for 14 years in a row by U.S. News & World Report ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Keri Mattox – Chief Communications and Administration Officer Ivan Tornos – President and Chief Executive Officer Suky Upadhyay – Executive Vice President and Chief Financial Officer Conference Call Participants Robbie Marcus – JPMorgan Drew Ranieri – Morgan Stanley Matt Taylor – Jefferies Shagun Singh – RBC Capital Markets Josh Jennings – TD Cowen Larry Biegelsen – Wells Fargo Chris Pas ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 (State or other jurisdiction of incorporation or organization) Delaware 13-4151777 (IRS Employer Identification No.) 345 East Main Street, Warsaw, IN 46580 (Address of principal executive offices) Telephone: (574) 373-3333 Securities registered pursuant to Section 12(b) of the Act: | Title of each class | Trading Symbol(s) | Name of each exchange on which registered | | --- | --- | --- | | Common Stock, $0.01 par value | ZBH | New York ...

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ET Company Participants Keri Mattox - SVP and Chief Communications & Administration Officer Bryan Hanson - Chairman, President & CEO Suketu Upadhyay - EVP & CFO Ivan Tornos - COO Conference Call Participants Travis Steed - Bank of America Merrill Lynch Richard Newitter - Truist Securities Philip Chickering - Deutsche Bank Michael Matson - Needham & Company Joshua Jennings - TD Cowen Ryan Zimmerman - BTIG Robert M ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED June 30, 2023 Commission File Number 001-16407 ZIMMER BIOMET HOLDINGS, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Delaware 13-4151777 (IRS Employer Identification No.) 345 East Main Street, Warsaw, IN 46580 (Address of principal ex ...